Antibiotic Dosing in Multiple Organ Dysfunction Syndrome

被引:79
|
作者
Ulldemolins, Marta [1 ,2 ,3 ]
Roberts, Jason A. [2 ,4 ,5 ]
Lipman, Jeffrey [2 ,4 ]
Rello, Jordi [1 ,3 ]
机构
[1] Univ Autonoma Barcelona, Crit Care Dept, Vall Hebron Univ Hosp, VHIR, Barcelona 08035, Spain
[2] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[3] CIBERES, Barcelona, Spain
[4] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; SEVERE SEPSIS; CLINICAL PHARMACOKINETICS; ANTIMICROBIAL THERAPY; GLOMERULAR-FILTRATION; ANTIBACTERIAL AGENTS; CREATININE CLEARANCE; HYPOALBUMINEMIA; PREDICTION;
D O I
10.1378/chest.10-2371
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Although early and appropriate antibiotic therapy remains the cornerstone of success for the treatment of septic shock, few data exist to guide antibiotic dose optimization in critically ill patients, particularly those with multiple organ dysfunction syndrome (MODS). It is well known that MODS significantly alters the patient's physiology, but the effects of these variations on pharmacokinetics have not been reviewed concisely. Therefore, the aims of this article are to summarize the disease-driven variations in pharmacokinetics and pharmacodynamics and to provide antibiotic dosing recommendations for critically ill patients with MODS. The main findings of this review are that the two parameters that vary with greatest significance in critically ill patients with MODS are drug volume of distribution and clearance. Disease- and clinician-driven changes lead to an increased volume of distribution and lower-than-expected plasma drug concentrations during the first day of therapy at least. Decreased antibiotic clearance is common and can lead to drug toxicity. In summary, "front-loaded" doses of antibiotic during the first 24 11 of therapy should account for the likely increases in the antibiotic volume of distribution. Thereafter, maintenance dosing must be guided by drug clearance and adjusted to the degree of organ dysfunction. CHEST 2011; 139(5):1210-1220
引用
收藏
页码:1210 / 1220
页数:11
相关论文
共 50 条
  • [21] Pediatric sepsis and multiple organ dysfunction syndrome
    Despond, O
    Proulx, F
    Carcillo, JA
    Lacroix, J
    CURRENT OPINION IN PEDIATRICS, 2001, 13 (03) : 247 - 253
  • [22] Microvascular thrombosis and multiple organ dysfunction syndrome
    Gando, Satoshi
    CRITICAL CARE MEDICINE, 2010, 38 (02) : S35 - S42
  • [23] Multiple organ dysfunction syndrome: a narrative review
    Johnson, D
    Mayers, I
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2001, 48 (05): : 502 - 509
  • [24] Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome
    Crouser, ED
    MITOCHONDRION, 2004, 4 (5-6) : 729 - 741
  • [25] The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome
    Wang, Houli
    Ma, Sui
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2008, 26 (06): : 711 - 715
  • [26] Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies
    Doctor, Allan
    Zimmerman, Jerry
    Agus, Michael
    Rajasekaran, Surender
    Wardenburg, Juliane Bubeck
    Fortenberry, James
    Zajicek, Anne
    Mairson, Emma
    Typpo, Katri
    PEDIATRIC CRITICAL CARE MEDICINE, 2017, 18 : S67 - S82
  • [27] Fecal microbiota transplantation for multiple organ dysfunction syndrome
    Klingensmith, Nathan J.
    Coopersmith, Craig M.
    CRITICAL CARE, 2016, 20
  • [28] Gut Microbiota and Multiple Organ Dysfunction Syndrome (MODS)
    Chen, Peng
    Billiar, Timothy
    GUT MICROBIOTA AND PATHOGENESIS OF ORGAN INJURY, 2020, 1238 : 195 - 202
  • [29] Survival in Fully Manifest Multiple Organ Dysfunction Syndrome
    Kleiman, David A.
    Barie, Philip S.
    SURGICAL INFECTIONS, 2014, 15 (04) : 445 - 449
  • [30] MULTIPLE ORGAN DYSFUNCTION SYNDROME - PATHOGENESIS AND APPROACH TO THERAPY
    STJOHN, RC
    DORINSKY, PM
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 15 (04) : 325 - 334